Publications

Giesler S, Biavasco F, Wertheimer T, Zeiser R, Vinnakota JM. 2025. Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndrome. Immunotherapy. 29:1-11. doi: 10.1080/1750743X.2025.2510893.

Grimmeisen M, Wang X, Weldle M, Sartory K, Benkhelifa S, Zhang Y, Dao T, Meyer J, Gorka O, Groß O, Jessen-Trefzer C. 2025. Synthesis and Evaluation of Trehalose-Based Mertansine Warheads for BCG Delivery of Anti-Cancer Agents. Chembiochem. 2025 May 27:e202500390. doi: 10.1002/cbic.202500390.

Sankowski R, Prinz M. 2025. A dynamic and multimodal framework to define microglial states. Nat Neurosci. 2025 May 20. doi: 10.1038/s41593-025-01978-3.

Teng YH, Appiah B, Andrieux G, Schrempp M, Rose K, Hofmann AS, Ku M, Beyes S, Boerries M, Hecht A. 2025. TGF-β signaling redirects Sox11 gene regulatory activity to promote partial EMT and collective invasion of oncogenically transformed intestinal organoids. Oncogenesis. 2025 May 20;14(1):17. doi: 10.1038/s41389-025-00560-7

Konwar S, Schroda S, Rogg M, Kleindienst J, Decker EL, Pohl M, Zieger B, Panse JP, Wang H, Grosse R, Schell C, Vidal S, Liu X, Gorzelanny C, Tschongov T, Häffner K. 2025. Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Invest. May 8:e180062. doi: 10.1172/JCI180062.

Osborn MJ, Panda S, Reineke TM, Tolar J, Nyström A. 2025. Progress in skin gene therapy: From the inside and out. Mol Ther. Mar 12:S1525-0016(25)00191-1. doi: 10.1016/j.ymthe.2025.03.017.

Geiger RA, Khera D, Tenthorey JL, Kochs G, Graf L, Emerman M, Malik HS. 2025. Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction. Sci Adv. May 2;11(18):eadu0062. doi: 10.1126/sciadv.adu0062.

Wess M, Rogg M, Gueib-Picard C, Merz A, Kössinger AL, Feilen T, Andreev G, Werner M, Frew IJ, Grabbert M, Schilling O, Schell C. 2025. Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment. iScience. 28(4):112198. doi: 10.1016/j.isci.2025.112198.

Arp AB, Abel Gutierrez A, Ter Beest M, Franken GA, Warner H, Rodgers Furones A, Kenyon AN, Jäger F, Cabrera-Orefice A, Kläsener K, van Deventer S, Droesen L, Dunlock VME, Classens R, Staniek J, Borst J, Reth M, Brandt U, Gros P, Kuijpers TW, Heemskerk MHM, Rizzi M, Querol Cano L, van Spriel AB. 2025. CD70 recruitment to the immunological synapse is dependent on CD20 in B cells. Proc Natl Acad Sci U S A. 122(16):e2414002122. doi: 10.1073/pnas.2414002122.

Röttele F, Zollner A, Mogler C, Yuksel M, Arikan C, Karl V, Aberle JH, Aberle SW, Kogler H, Vécsei A, Vodopiutz J, Salié H, Gräser A, Krimmel L, Martin P, Lurz E, Maier FI, Woelfle L, Nobre S, Goncalves I, Kern L, Schwemmle M, Boettler T, Hofmann M, Hasselblatt P, Thimme R, Tilg H, Müller T, Vogel GF, Bengsch B. 2025.  Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19. Gut. Apr 5:gutjnl-2024-333880. doi: 10.1136/gutjnl-2024-333880.

Schlösser RM, Krumbach F, Corrales E, Andrieux G, Preisinger C, Liss F, Golzmann A, Boerries M, Becker K, Knüchel R, Garczyk S, Lüscher B. 2025. Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal-like and malignant urothelial cells. Mol Oncol. Apr 1. doi: 10.1002/1878-0261.70019.

Zähringer A, Morgado I, Erny D, Ingelfinger F, Gawron J, Chatterjee S, Wenger V, Schmidt D, Schwöbel LF, Adams RC, Langenbach M, Hartmann A, Osswald N, Wolf J, Schlunck G, Briquez PS, Grueter K, Ruess DA, Frew I, Burk AC, Holzmüller V, Grimbacher B, Michonneau D, Andrieux G, Socié G, Kolter J, Börries M, Follo M, Blaeschke F, Sevenich L, Prinz M, Zeiser R, Vinnakota JM. 2025. AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling. Blood Adv. Mar 31:bloodadvances.2024015000. doi: 10.1182/bloodadvances.2024015000.

Fernandez-Orth J, Koyunlar C, Weiss JM, Gioacchino E, de Looper HWJ, Andrieux G, Ter Borg M, Zink J, Gonzalez Menendez I, Hoogenboezem R, Yigit BI, Gussinklo K, Mulet-Lazaro R, Wantzen C, Pfeiffer S, Molnar C, Bindels E, Bohler S, Sanders MA, Quintanilla-Martinez L, Wlodarski MW, Boerries M, Touw IP, Niemeyer C, Erlacher M, de Pater E. 2025. Hematological phenotypes in GATA2 deficiency syndrome arise from aging maladaptation to proliferation and somatic events. Blood Adv. 2025 Mar 26:bloodadvances.2024015106. doi: 10.1182/bloodadvances.2024015106.

Andreev G, Vollmer T, Zirngibl M, Werner M, Grabbert M, Schilling O, Rogg M, Schell C. 2025. Spatial correlation of the extracellular matrix to immune cell phenotypes in the tumor boundary of ccRCC revealed by cyclic immunohistochemistry. Lab Invest. 2025 Mar 20:104130. doi: 10.1016/j.labinv.2025.104130.

Staniek J, Rizzi M. 2025. Signaling Activation and Modulation in Extrafollicular B Cell Responses. Immunol Rev. 330(1):e70004. doi: 10.1111/imr.70004.

Karl V, Hofmann M, Thimme R. 2025. Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination. J Virol. Mar 3:e0135024. doi: 10.1128/jvi.01350-24.